Reuters logo
BUZZ-India's Divi's Labs falls; U.S. FDA observations more than procedural -report
September 27, 2017 / 5:42 AM / 25 days ago

BUZZ-India's Divi's Labs falls; U.S. FDA observations more than procedural -report

** Divi’s Laboratories Ltd falls as much as 9.4 pct to 870.1 rupees

** Observations issued by the U.S. FDA on its Visakhapatnam plant question data integrity and cite inadequate cleaning procedure, news agency BloombergQuint reports (bit.ly/2hwaedM)

** Divi’s Labs said last week it received six observations from the FDA, saying it was procedural in nature

** The drug maker did not immediately respond to Reuters’ request for comment on the BlooombergQuint report

** Stock posts biggest intraday pct fall since March 21

** Stock has fallen about 28 pct in the last 12 months up to Tuesday’s close

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below